EU: ‘Urgent Action’ Needed From Industry & Member States To Curb GLP-1 Shortages

The off-label “cosmetic” use of GLP-1 receptor agonists such as Ozempic and Wegovy is contributing to global shortages of these drugs, prompting the European Medicines Agency to ask member states and manufacturers to “control and optimize” their use.